Om

Niki BioSolutions, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic products for oncology and infectious diseases. Its current pipeline includes repurposed drug candidates and small molecules under clinical and preclinical evaluation, with programs aimed at treating neuroblastoma, bacterial infections, and coronavirus disease. The company also works on additional therapeutic assets targeting unmet medical needs across cancer and infectious disease areas. Based in Princeton, New Jersey, Niki BioSolutions operates through subsidiaries and maintains a product portfolio centered on drug development and translational research. Its role in the financial market reflects that of a specialized biotechnology issuer tied to early-stage clinical progress and pipeline advancement.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NIKI BIOSOLUTIONS MED ENDAVU: Køb Niki BioSolutions ($NIKI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Niki BioSolutions, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.